Initiative credited with creating unprecedented momentum for kidney advocacy
NEW YORK , June 1, 2022 /PRNewswire/ -- It's been an unprecedented year for kidney advocacy. The National Kidney Foundation (NKF) today announced its NKF Voices for Kidney Health™ program gained significant increases in both congressional support and funding for kidney-disease related research and prevention in its first year of operations.
NKF gained significant increases in both congressional support & funding for kidney-disease related research & prevention.
Launched one year ago today, Voices for Kidney Health is a diverse nationwide community of dedicated advocates committed to improving the lives of those living with kidney disease through meaningful policy change. By sharing their own life stories with elected officials and other policy leaders, Voices advocates work to advance policies that expand access to home dialysis, work toward transplants for all, protect living organ donors, promote health equity, and accelerate investment in kidney disease prevention and research.
The impact that Voices for Kidney Health has already had on advancing pro-kidney health policies is clear. During the past year, Voices advocacy resulted in increases in congressional funding for kidney-disease related research and prevention activities at the Centers for Disease Control and Prevention (CDC) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDD). This trend has continued into 2022, with Voices advocates successfully lobbying 82 members of Congress – a new record - to sign NKF's annual kidney funding letter to support continued increases at CDC and NIDD.
Voices advocates also generated tens of thousands of letters to federal, state, and local policymakers, collected thousands of signatures on a petition calling for prioritization of at-risk kidney community members for COVID-19 vaccinations, and registered thousands of new kidney community advocates to join the fight.
Additionally, NKF Voices for Kidney Health advocates secured unprecedented support in State legislative sessions with eight new states passing Living Donor Protection Acts (LDPA) and Chronic Kidney Disease task force legislation in 2022. Congressional support for kidney legislation is also unrivaled when compared to previous years. The federal LDPA (H.R. 1255/S. 377) currently has 125 cosponsors in the House and 40 cosponsors in the Senate, while18 Representatives have signed on in support of the newly introduced Improving Access to Home Dialysis Act (H.R. 5426).
"As we celebrate the achievements of the past year, we must also acknowledge that there is still much work to be done," said Kevin Longino , Chief Executive Officer of the NKF and a kidney transplant recipient. "Racial and ethnic disparities in the awareness, diagnosis, and treatment of kidney disease lead to worse outcomes for kidney patients in communities of color. Patients face unequal access to kidney transplant, the optimal treatment for kidney failure. Life, long-term care, and disability insurers can still discriminate against living organ donors in almost half of U.S. states. These are just a few of the issues we're addressing as Voices for Kidney Health enters its second year."
"NKF's gratitude to our Voices advocates cannot be overstated," Longino added. "We are continually impressed by their commitment to improving the lives of their fellow kidney patients, and it is a privilege to work with each and every one of them. Thanks to their continued dedication, Voices for Kidney Health will continue to represent the sound of positive change for kidney patients nationwide."
Interested in joining the fight for kidney health? For more details on how to become an advocate and join Voices for Kidney Health, go to voices.kidney.org.
In the United States , 37 million adults are estimated to have chronic kidney disease—and approximately 90 percent don't know they have it. 1 in 3 adults in the U.S. are at risk for chronic kidney disease. Risk factors for kidney disease include: diabetes, high blood pressure, heart disease, obesity, and family history. People of Black or African American, Hispanic or Latino, American Indian or Alaska Native, Asian American, or Native Hawaiian or Other Pacific Islander descent are at increased risk for developing the disease. Blacks or African Americans are almost 4 times more likely than White Americans to have kidney failure. Hispanics are 1.3 times more likely than non-Hispanics to have kidney failure.
Approximately 785,000 Americans have irreversible kidney failure and need dialysis or a kidney transplant to survive. More than 500,000 of these patients receive dialysis at least three times per week to replace kidney function. Nearly 100,000 Americans are on the waitlist for a kidney transplant right now. Depending on where a patient lives, the average wait time for a kidney transplant can be upwards of three to seven years.
About the National Kidney Foundation
The National Kidney Foundation (NKF) is the largest, most comprehensive, and longstanding patient-centric organization dedicated to the awareness, prevention, and treatment of kidney disease in the U.S. For more information about NKF, visit www.kidney.org.
Facebook.com twitter.com/nkf www.kidney.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/nkfs-voices-for-kidney-health-celebrates-record-breaking-one-year-anniversary-301559341.html
SOURCE The National Kidney Foundation
The FDA suggested Friday there could be a link between Novavax's Covid vaccine and heart inflammation, and NVAX stock plummeted.
U.S. Food and Drug Administration staff said on Friday Novavax Inc's vaccine reduces the risk of mild-to-severe COVID-19 and that it was likely the shot could provide some level of protection against the Omicron variant. The FDA analyzed data from Novavax's trial before the Omicron and Delta variant became the dominant strains. "Based on the efficacy estimate in the clinical trial of this vaccine, it is more likely than not that the vaccine will provide some meaningful level of protection against COVID-19 due to Omicron, in particular against more severe disease," FDA staff said.
'Multiple events' of heart inflammation were reported after administering the Covid-19 vaccine, especially among younger men, according to the FDA.
There are two sides to every coin. For penny stocks, or tickers that trade for less than $5 per share, this rings especially true. As some of the most divisive names on the Street, they are either met with resounding praise or forceful discontent. Going beyond the argument that you get more for your money, even minor price appreciation can result in massive percentage gains. However, some investors prefer to avoid these stocks entirely, as the fact that shares are trading at such depressed level
Novavax Inc.’s (NASDAQ: NVAX) stock tanked more than 20% Friday afternoon after the Food and Drug Administration shared concerns about a potential connection between heart inflammation and the company’s experimental Covid-19 vaccine, which the agency expects to take into consideration next week for potential emergency use authorization. As part of a briefing released Friday, the FDA said its vaccines advisory committee will meet Tuesday to discuss the Gaithersburg company's submission and “provide recommendations on whether, based on the totality of scientific evidence available, the benefits of the Novavax Covid-19 Vaccine 2-dose primary series outweigh its risks for use in individuals 18 years of age and older.” The risks, according to the documents, namely include the potential for inflammation in and around the heart, known as myocarditis and pericarditis.
Pharmaceutical behemoth Pfizer (NYSE: PFE) has racked up successes during the COVID-19 outbreak, as the first to enter the market with a vaccine in December 2020 and a pill treatment in December 2021. Outside of the Covid space, Pfizer sells a number of megablockbusters such as blood-thinner Eliquis, breast-cancer drug Ibrance, pneumonia vaccine Prevnar, and arthritis treatment Xeljanz. The company also sees higher growth coming from blockbuster drugs Vyndaqel for cardiovascular disease and Inlyta and Xtandi for cancer treatments.
Even if you're keeping up with the latest official recommendations about COVID- prevention, this may be an uncertain and frustrating time. As summer approaches, what is safe to do? How should we approach social activities now that it's clear COVID is a chronic part of our lives? Here's an important overlooked factor one doctor wishes we knew about COVID now. Her point: We need to consider what's safe, but also what's healthy. Read on to find out more—and to ensure your health and the health of o
"Christian Bale can do it for a movie role and that is acceptable."View Entire Post ›
Many people who have taken Paxlovid are reporting a return of symptoms. Here's why it may be happening, and why doctors still recommend using the medication.
Under current Centers for Disease Control and Prevention guidelines, 13 of California’s 58 counties moved today into “high” levels of Covid and are supposed to require masks in indoor public spaces. They include some of the state’s most populous counties, like Santa Clara and Sacramento as well as some of its smallest, like Del Norte […]
Now Florida Gov. DeSantis wants to strip medical care from transgender children and adults.
Pfizer Inc. and BioNTech SE have asked the U.S. Food and Drug Administration to authorize their three-dose vaccine for children aged six months to five years, in a move that could add roughly 19 million young children to the program.
Organon Canada Inc., an affiliate of Organon (NYSE: OGN), a global women's healthcare company, which employs over 120 people across Canada, today announced the publication of the company inaugural Environmental, Social, and Governance (ESG) Report for 2021. The ESG report introduces the company's ESG platform, known as Her Promise, and details how the company is working to help women and girls achieve the full potential of their promise through better health. The publication of the ESG Report an
Over the last two years, the coronavirus has made one million Americans so severely ill that they have died as a result. While that tragic outcome is a worst case scenario, there are a wide variety of ways a COVID case can pan out. Many people don't even know they're infected until they test positive because they never develop symptoms, while others get sick enough to need hospitalization. The Centers for Disease Control and Prevention (CDC) has pinpointed a number of factors that could make you
The Pennsylvania Democratic Senate nominee's cardiologist said in a letter that Fetterman did not follow doctor’s orders after a 2017 appointment.
Your weekly exercise can come in many forms, from an intense HIIT class to a leisurely bike ride.
CenterWell Home Health, Humana Inc.’s rebranded home health initiative, is expanding into 14 new states, the company announced this week. CenterWell Home Health is formed out of Kindred at Home, which Humana (NYSE: HUM) acquired in August 2021. This acquisition expanded the Louisville-based health care giant’s footprint in the home health offering space.
Regeneron will gain exclusive worldwide development, commercialization, and manufacturing rights to the drug Libtayo.
We're entering the third pandemic summer, and it's a confusing time. Cases are up nationwide. Hospitalizations are rising but not to the extent of previous COVID-19 waves. People over 50 are advised to get a fourth vaccine dose. But where are we, really, and what does the future of COVID look like as we head into the fall and beyond? Dr. Anthony Fauci, the nation's top infectious-disease expert, shed some light on this during an interview this week. Read on to find out more—and to ensure your he
Researchers are drawing attention to a rise in poisonings in children involving the sleep aid melatonin — including a big jump during the pandemic. Last year, U.S. poison control centers received more than 52,000 calls about children consuming worrisome amounts of the dietary supplement — a six-fold increase from about a decade earlier. Most such calls are about young children who accidentally got into bottles of melatonin, some of which come in the form of gummies for kids.